Context Therapeutics GAAP EPS of -$0.31

LyondellBasell's Crucial Moment: Will The Board Protect The Dividend? Source link{...}

We’ve detected you are on Internet Explorer. For the best Barrons.com experience, please update to a modern browser. Summary Summary{...}

VANCOUVER, BC, Nov. 14, 2025 /CNW/ – NGEx Minerals Ltd. (“NGEx Minerals” “NGEx” or the “Company”) (TSX:NGEX) (OTCQX:NGXXF) is pleased to{...}